At close: December 20 at 4:00:02 PM EST
After hours: December 20 at 6:56:56 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
--
210.0000
Operating Expense
63,378.0000
37,809.0000
27,455.0000
9,292.0000
Operating Income
-63,378.0000
-37,809.0000
-27,455.0000
-9,082.0000
Net Non Operating Interest Income Expense
6,056.0000
979.0000
114.0000
2.0000
Other Income Expense
-125.0000
525.0000
-369.0000
-107.0000
Pretax Income
-57,447.0000
-36,305.0000
-27,710.0000
-9,187.0000
Net Income Common Stockholders
-57,447.0000
-36,305.0000
-27,710.0000
-9,187.0000
Diluted NI Available to Com Stockholders
-57,447.0000
-36,305.0000
-27,710.0000
-9,187.0000
Basic EPS
-2.38
-1.42
-2.13
-0.94
Diluted EPS
-2.38
-1.42
-2.13
-0.94
Basic Average Shares
26,968.1980
25,574.3600
12,980.0000
9,731.0000
Diluted Average Shares
26,968.1980
25,574.3600
12,980.0000
9,731.0000
Total Operating Income as Reported
-63,378.0000
-37,809.0000
-29,192.0000
-12,056.0000
Total Expenses
63,378.0000
37,809.0000
27,455.0000
9,292.0000
Net Income from Continuing & Discontinued Operation
-57,447.0000
-36,305.0000
-27,710.0000
-9,187.0000
Normalized Income
-57,370.0000
-36,830.0000
-27,341.0000
-9,080.0000
Interest Income
7,454.0000
2,349.0000
114.0000
2.0000
Interest Expense
1,398.0000
1,370.0000
--
--
Net Interest Income
6,056.0000
979.0000
114.0000
2.0000
EBIT
-56,049.0000
-34,935.0000
-27,710.0000
-9,082.0000
EBITDA
-55,605.0000
-34,562.0000
-27,368.0000
-8,937.0000
Reconciled Depreciation
444.0000
373.0000
342.0000
145.0000
Net Income from Continuing Operation Net Minority Interest
-57,447.0000
-36,305.0000
-27,710.0000
-9,187.0000
Total Unusual Items Excluding Goodwill
-77.0000
525.0000
-369.0000
-107.0000
Total Unusual Items
-77.0000
525.0000
-369.0000
-107.0000
Normalized EBITDA
-55,528.0000
-35,087.0000
-26,999.0000
-8,830.0000
12/31/2021 - 2/2/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AVBP ArriVent BioPharma, Inc.
26.09
+1.72%
KYTX Kyverna Therapeutics, Inc.
4.0000
+3.36%
BOLD Boundless Bio, Inc.
2.5900
+2.78%
LXEO Lexeo Therapeutics, Inc.
6.28
+3.97%
SPRB Spruce Biosciences, Inc.
0.4000
+4.68%
PEPG PepGen Inc.
3.6300
-11.25%
GUTS Fractyl Health, Inc.
1.7900
-1.65%
MGNX MacroGenics, Inc.
3.1800
0.00%
DSGN Design Therapeutics, Inc.
6.25
+4.34%
VIGL Vigil Neuroscience, Inc.
1.7000
+2.41%